Serological Cytokine and chemokine profile in pregnant women with COVID19 in Mexico City
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
On January 30th, 2020, the WHO declared the outbreak of COVID19, a disease due to the new coronavirus called SARS-CoV-2. Certain comorbidities, symptoms and signs are characteristic of COVID19 in the general population and in pregnant women. However, pregnant women are considered as a high-risk group for COVID19. To know about the frequency of comorbidities, signs and symptoms, the presence of lymphopenia, antibodies response to SARS-CoV2 and cytokine and chemokine serum concentration, six pregnant women with COVID19 were studied at the moment of admission. The lower concentration of CCL17 was detected in the Pregnant COVID19 group, similar concentration of IL-6 was also detected in non-pregnant and pregnant COVID19 patients. Our result show that pregnant and non-pregnant women with COVID19 has similar cytokine profile.
Article activity feed
-
SciScore for 10.1101/2020.07.14.20153585: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement Consent: Eighteen women were enrolled after obtaining a signed informed consent. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable Eighteen women were enrolled after obtaining a signed informed consent. Table 2: Resources
Software and Algorithms Sentences Resources Statistical Analysis: Statistical analysis was performed using Graph Pad Prism® version 6 software (GraphPad Software, San Diego, CA, USA), and SPSS software, compilation 1.0.0.1347. Graph Pad Prism®suggested: (GraphPad Prism, RRID:SCR_002798)GraphPadsuggested: (GraphPad Prism, RRID:SCR_002798)SPSSsuggested: (SPSS, RRID:SCR_002865)Results from OddPub: We …
SciScore for 10.1101/2020.07.14.20153585: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement Consent: Eighteen women were enrolled after obtaining a signed informed consent. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable Eighteen women were enrolled after obtaining a signed informed consent. Table 2: Resources
Software and Algorithms Sentences Resources Statistical Analysis: Statistical analysis was performed using Graph Pad Prism® version 6 software (GraphPad Software, San Diego, CA, USA), and SPSS software, compilation 1.0.0.1347. Graph Pad Prism®suggested: (GraphPad Prism, RRID:SCR_002798)GraphPadsuggested: (GraphPad Prism, RRID:SCR_002798)SPSSsuggested: (SPSS, RRID:SCR_002865)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:However, the limitation is the small number of cases for analysis, due to the time when the pregnant patients requested medical attention, and it was not possible to monitor them for a long time. There are few studies available about the effect of COVID19 in pregnancy and it has published that pregnant women with COVID are not sufficiently taken into account in clinical research (51), especially in immunology. This is important because contrary to assume that pregnancy in COVID19 could lead to high number of fatal outcomes such as SARS (27), despite data shows just the opposite. So, if pregnancy is a condition were the immune system is capable to handle this viral challenge we must to learn more about tolerance in immune response in pregnancy, and apply that knowledge to successful treatment for the non-pregnant patients.
Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-